AYR Wellness Reports Second Quarter 2023 Results Revenue up 18% Y/Y to $116.7 Million, Excluding Discontinued Operations Company Delivers Record Adjusted EBITDA1 of $29.4 Million, up 78% Y/Y, 12% Sequentially, with Adjusted EBITDA Margin of 25% GAAP Loss from Operations Improved 81% Y/Y, 79% Sequentially to $(4.5) Million, Excluding... Read more

Cresco Labs Reports Second Quarter 2023 Results Year-of-the-Core initiatives delivered strong improvements in gross margin, adjusted EBITDA and operating cash flow CHICAGO–(BUSINESS WIRE)–Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most... Read more